Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

6.96USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$6.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,536
52-wk High
$23.68
52-wk Low
$5.51

Chart for

About

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant unmet medical needs. The Company's product pipeline includes PTG-100, PTG-200 and PTG-300. Its primary focus is on developing... (more)

Overall

Beta: --
Market Cap(Mil.): $169.06
Shares Outstanding(Mil.): 24.19
Dividend: --
Yield (%): --

Financials

  PTGX.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.30 -- --
ROI: -30.74 0.60 13.80
ROE: -30.93 -2.18 15.29

Earnings vs. Estimates